ALFREDA SHIELDS: Open Payments
NPI 1497021810 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,889 in 28 payments from 7 companies in 2025. Trend: 2023 $624 · 2024 $1,798 · 2025 $1,889
Food & beverage: $1,778Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $589 |
| Teva Pharmaceuticals USA, Inc. | 10 | $515 |
| Neurocrine BioSciences, Inc. | 3 | $245 |
| Janssen Pharmaceuticals, Inc | 7 | $188 |
| ABBVIE INC. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $105 |
Products named: COBENFY, AUSTEDO XR, INGREZZA, INVEGA SUSTENNA, UZEDY, VRAYLAR, REXULTI, LYBALVI.
Industry payments across MO — which companies pay providers there.
